Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Vision and ambition

Our vision for Innovation at LUDC/Exodiab:

"To create the world´s leading center for research and innovation in diabetes/metabolism".

By this we mean:

To develop LUDC/EXODIAB to become a major partner to the industry in supporting the development of novel treatment approaches, thus strengthening the consortium, resulting in attracting ambitious PhD Students and funding collaboration projects.

By:

  • Collaborating with the industry to increase our understanding of unmet patient and market needs.
  • Partnering with other organizations that can complement our skills, in particular in the field of drug discovery and medical technology in order to develop projects with strong IP.
  • Build a portfolio of IP projects that are attractive to external financing sources.

LUDC´s Innovation Ambition:

  • Give access to our platforms and knowledge, sharing knowledge and competence
  • Collaboration projects to speed up new drug discovery, diagnostic tools and other medical technology development
  • Identification of research areas with high commercial potential
  • Increase knowledge/interest in IP generation

Position LUDC as a major partner to the industry to develop new approaches for treatment of diabetes and its complications.

Contact us

Annie George Chandy, Innovation manager:

+46 40 39 11 55

+46 70 246 97 97
annie [dot] chandy [at] med [dot] lu [dot] se